SG11201701104SA - Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride - Google Patents

Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Info

Publication number
SG11201701104SA
SG11201701104SA SG11201701104SA SG11201701104SA SG11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA
Authority
SG
Singapore
Prior art keywords
morpholin
yloxy
phenyl
large scale
scale production
Prior art date
Application number
SG11201701104SA
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Ramasastri Kambhampati
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of SG11201701104SA publication Critical patent/SG11201701104SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201701104SA 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride SG11201701104SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4010CH2014 2014-08-16
PCT/IN2014/000666 WO2016027275A1 (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Publications (1)

Publication Number Publication Date
SG11201701104SA true SG11201701104SA (en) 2017-03-30

Family

ID=52339255

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701104SA SG11201701104SA (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Country Status (28)

Country Link
US (1) US9802896B2 (ko)
EP (1) EP3180334B1 (ko)
JP (1) JP6385580B2 (ko)
KR (1) KR101860487B1 (ko)
CN (1) CN106573925B (ko)
AP (1) AP2017009753A0 (ko)
AU (1) AU2014403999B2 (ko)
BR (1) BR112017002922B1 (ko)
CA (1) CA2957494C (ko)
CY (1) CY1121253T1 (ko)
DK (1) DK3180334T3 (ko)
EA (1) EA032823B1 (ko)
ES (1) ES2693378T3 (ko)
HK (1) HK1231472A1 (ko)
HR (1) HRP20181801T1 (ko)
HU (1) HUE041465T2 (ko)
IL (1) IL250412B (ko)
LT (1) LT3180334T (ko)
MX (1) MX364931B (ko)
NZ (1) NZ728915A (ko)
PL (1) PL3180334T3 (ko)
PT (1) PT3180334T (ko)
RS (1) RS57927B1 (ko)
SG (1) SG11201701104SA (ko)
SI (1) SI3180334T1 (ko)
TR (1) TR201816175T4 (ko)
WO (1) WO2016027275A1 (ko)
ZA (1) ZA201700936B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020024264A2 (pt) 2018-05-31 2021-02-23 Suven Life Sciences Limited agonista invertido do receptor de histamina-3, uso de um agonista invertido do receptor de histamina-3 para a fabricação de um medicamento e composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
EP2674420B1 (en) * 2011-02-04 2016-01-27 Ihara Chemical Industry Co., Ltd. Method for producing aminophenyl pyrimidinyl alcohol derivative, and synthesis intermediate thereof
AP3340A (en) * 2011-02-23 2015-07-31 Suven Life Science Ltd Novel compounds as histamine H3 receptor ligands

Also Published As

Publication number Publication date
SI3180334T1 (sl) 2019-01-31
AU2014403999B2 (en) 2017-12-14
ZA201700936B (en) 2019-07-31
CY1121253T1 (el) 2020-05-29
AU2014403999A1 (en) 2017-02-23
RS57927B1 (sr) 2019-01-31
MX364931B (es) 2019-05-14
AP2017009753A0 (en) 2017-02-28
BR112017002922B1 (pt) 2023-01-03
HRP20181801T1 (hr) 2018-12-28
JP6385580B2 (ja) 2018-09-05
DK3180334T3 (en) 2018-11-26
LT3180334T (lt) 2018-11-12
CN106573925B (zh) 2020-04-10
MX2017002043A (es) 2017-05-04
ES2693378T3 (es) 2018-12-11
IL250412B (en) 2019-11-28
NZ728915A (en) 2018-01-26
EP3180334B1 (en) 2018-09-26
CN106573925A (zh) 2017-04-19
HUE041465T2 (hu) 2019-05-28
PL3180334T3 (pl) 2019-03-29
EP3180334A1 (en) 2017-06-21
JP2017525761A (ja) 2017-09-07
US9802896B2 (en) 2017-10-31
EA032823B1 (ru) 2019-07-31
KR101860487B1 (ko) 2018-05-23
CA2957494A1 (en) 2016-02-25
WO2016027275A1 (en) 2016-02-25
TR201816175T4 (tr) 2018-11-21
PT3180334T (pt) 2018-11-16
BR112017002922A2 (pt) 2017-12-05
IL250412A0 (en) 2017-03-30
KR20170036044A (ko) 2017-03-31
US20170260135A1 (en) 2017-09-14
CA2957494C (en) 2018-08-28
HK1231472A1 (zh) 2017-12-22
EA201790388A1 (ru) 2017-06-30

Similar Documents

Publication Publication Date Title
HRP20200216T1 (hr) Novi metilpiperidinski spojevi, korisni za inhibiranje mikrosomske prostaglandin-e2-sintaze-1
IL257390B (en) Salts of 1-((4-methoxymethyl)-4-(((s2,r1)-2-phenyl-cyclopropylamine)methyl)piperidine-1-yl)methyl)-cyclobutane-carboxylic acid as lsd1 inhibitors
SI2981520T1 (sl) Novi proces za sintezo 1-(2-((2,4-dimetilfenil)tio)fenil)piperazina
IL265067B (en) Process for preparing btk inhibitors
HUP1700197A2 (en) Industrial procedure for production of cariprazine
HRP20181801T1 (hr) Postupak za masovnu proizvodnju n-[4-(1-ciklobutil piperidin-4-iloksi)fenil]-2-(morfolin-4-il)acet amid dihidroklorida
DK3247699T3 (da) Proces til produktion of 2-[4-(cyclopropancarbonyl)phenyl]-2-methyl-propannitril
IL249282B (en) A process for the preparation of 5,3-bis(haloalkyl)pyrazoles using acylation of ketamines
IL247895A0 (en) Process for the preparation of n-[3-(benzylcarbamoyl)phenyl]-h1-pyrazole-5-carboxamides
TH1701000768A (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
TH169412B (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
TH1701000769A (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ 1-ไอโซโพรพิล-3-{5-[1-(3-เมทอก ซีโพรพิล)พิเพอริดิน-4-อิล]-[1,3,4]ออกซาไดอะโซล-2-อิล}-1h-อินดาโซลออกซาเลต
GB201523002D0 (en) Thiazolidine acid drug intermediates LN- acetyl-thia-proline synthesis method
GB201523219D0 (en) Piperidine-carboxylic acid amide pharmaceutical intermediate N- (2,6- dimethylphenoxy) - 4-pyridinecarboxamide synthesis method
PL3209661T3 (pl) Sposób wytwarzania polimorfu rywaroksabanu